Coloplast A/S

COLOB-DC

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about COLOB-DC

Signal
Opinion
Expert
TOP PICK
TOP PICK
January 13, 2020
A Danish healthcare company that focuses on wound care, skin care, digestion and other areas. Smart managers continue to focus on R&D--he likes that. Since 2015, they've increased clinical studies by 2.5x and patents by 10x. They've spent free cash flow very well. Revenues have grown 9% annually even during the Great Recession. (Analysts’ price target is $10.74)
Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
January 13, 2020
A Danish healthcare company that focuses on wound care, skin care, digestion and other areas. Smart managers continue to focus on R&D--he likes that. Since 2015, they've increased clinical studies by 2.5x and patents by 10x. They've spent free cash flow very well. Revenues have grown 9% annually even during the Great Recession. (Analysts’ price target is $10.74)
PAST TOP PICK
PAST TOP PICK
October 12, 2018

(A Top Pick August 21/17, Up 24%) Colostomy bags and catheters, playing the aging demographic. Gained market share in US. Free cash flow is above competitors. Dividend grows about 10-15% per year. Investors go here to hide, so it goes up when markets go down. Buy on a pullback.

Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
October 12, 2018

(A Top Pick August 21/17, Up 24%) Colostomy bags and catheters, playing the aging demographic. Gained market share in US. Free cash flow is above competitors. Dividend grows about 10-15% per year. Investors go here to hide, so it goes up when markets go down. Buy on a pullback.

TOP PICK
TOP PICK
August 21, 2017

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
August 21, 2017

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

Showing 1 to 3 of 3 entries
  • «
  • 1
  • »